[Delta 4-3-oxosteroid 5 beta-reductase deficiency].
Kondo
K H
KH
Department of Surgery 1, Miyazaki Medical College.
Kai
M H
MH
Setoguchi
T
T
D001647:Bile Acids and Salts / Q000378:metabolism / Q000652:urine; D015415:Biomarkers / Q000652:urine; D002635:Chenodeoxycholic Acid / Q000627:therapeutic use; D002756:Cholagogues and Choleretics / Q000627:therapeutic use; D019826:Cholic Acid; D002793:Cholic Acids / Q000627:therapeutic use; D003937:Diagnosis, Differential; D006801:Humans; D007231:Infant, Newborn; D008661:Metabolism, Inborn Errors / Q000209:etiology / Q000503:physiopathology; D010088:Oxidoreductases / Q000172:deficiency*; D011379:Prognosis; D014580:Ursodeoxycholic Acid / Q000627:therapeutic use
D001647:Bile Acids and Salts; D015415:Biomarkers; D002756:Cholagogues and Choleretics; D002793:Cholic Acids; D002635:Chenodeoxycholic Acid; D014580:Ursodeoxycholic Acid; D010088:Oxidoreductases; C051860:cholestenone 5 beta-reductase; D019826:Cholic Acid